Your prediction
Quoin Pharmaceuticals Ltd. ADR Stock
For the coming years our community has positive and negative things to say abot the Quoin Pharmaceuticals Ltd. ADR stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.
Pros and Cons of Quoin Pharmaceuticals Ltd. ADR in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quoin Pharmaceuticals Ltd. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals Ltd. ADR | - | - | - | - | - | - | - |
| Medpace Holdings Inc | 0.690% | -1.043% | -6.131% | 42.780% | 46.799% | 145.208% | 295.500% |
| Galapagos N.V. | 2.050% | -2.544% | 1.055% | 4.196% | 1.977% | -29.029% | -65.973% |
| Ironwood Pharmaceuticals | -4.050% | -2.632% | 12.121% | -11.905% | -29.524% | -73.948% | -69.485% |
Comments
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) had its price target lowered by analysts at Maxim Group from $15.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for QNRX provided by MarketBeat
